Skip to main content
Premium Trial:

Request an Annual Quote

Kirk Calhoun

Great Basin Scientific has elected Kirk Calhoun to its board of directors and announced that he will chair the firm's audit committee. He is replacing Steven Aldous, who is retiring. Calhoun was a partner at Ernst & Young from 1975 until he retired in 2002, and he currently serves on the boards of Response Genetics, Ryerson Holding Corporation, and NeuroSigma.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.